TreeWAS – Variant ID: rs62192635

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
C44 Other malignant neoplasms of skin	1.000	0.000
C44.3 Skin of other and unspecified parts of face	0.994	0.006
C44.5 Skin of trunk	0.993	0.007
C44.6 Skin of upper limb, including shoulder	0.983	0.017
C44.1 Skin of eyelid, including canthus	0.969	0.031
C44.0 Skin of lip	0.969	0.031
C44.2 Skin of ear and external auricular canal	0.961	0.039
C44.4 Skin of scalp and neck	0.949	0.051
C44.9 Malignant neoplasm of skin, unspecified	0.836	0.164
C43-C44 Melanoma and other malignant neoplasms of skin	0.793	0.207
C43 Malignant melanoma of skin	0.747	0.253
C44.8 Overlapping lesion of skin	0.717	0.283
C43.6 Malignant melanoma of upper limb, including shoulder	0.706	0.294
C43.5 Malignant melanoma of trunk	0.665	0.335
C44.7 Skin of lower limb, including hip	0.656	0.344
C43.3 Malignant melanoma of other and unspecified parts of face	0.538	0.462
C43.8 Overlapping malignant melanoma of skin	0.536	0.464
C43.2 Malignant melanoma of ear and external auricular canal	0.536	0.464
C43.1 Malignant melanoma of eyelid, including canthus	0.536	0.464
C43.0 Malignant melanoma of lip	0.536	0.464
C43.9 Malignant melanoma of skin, unspecified	0.521	0.479
C43.4 Malignant melanoma of scalp and neck	0.480	0.520
C43.7 Malignant melanoma of lower limb, including hip	0.423	0.577
Chapter II Neoplasms	0.068	0.932
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.064	0.936
C71 Malignant neoplasm of brain	0.061	0.939
D03 Melanoma in situ	0.061	0.939
D00-D09 In situ neoplasms	0.061	0.939
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.060	0.940
D03.6 Melanoma in situ of upper limb, including shoulder	0.059	0.941
D37-D48 Neoplasms of uncertain or unknown behaviour	0.058	0.942
C91 Lymphoid leukaemia	0.057	0.943
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.056	0.944
C91.1 Chronic lymphocytic leukaemia	0.055	0.945
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.054	0.946
C64-C68 Malignant neoplasms of urinary tract	0.054	0.946
G45.9 Transient cerebral ischaemic attack, unspecified	0.054	0.946
C71.3 Parietal lobe	0.052	0.948
D03.3 Melanoma in situ of other and unspecified parts of face	0.052	0.948
C40-C41 Malignant neoplasms of bone and articular cartilage	0.052	0.948
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.051	0.949
C71.4 Occipital lobe	0.051	0.949
D47.3 Essential (haemorrhagic) thrombocythaemia	0.050	0.950
C71.0 Cerebrum, except lobes and ventricles	0.050	0.950
C71.1 Frontal lobe	0.050	0.950
C64 Malignant neoplasm of kidney, except renal pelvis	0.050	0.950
C49 Malignant neoplasm of other connective and soft tissue	0.049	0.951
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.049	0.951
C83 Diffuse non-Hodgkin's lymphoma	0.047	0.952
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.047	0.953
D03.5 Melanoma in situ of trunk	0.046	0.954
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.046	0.954
C70 Malignant neoplasm of meninges	0.046	0.954
C69 Malignant neoplasm of eye and adnexa	0.046	0.954
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.046	0.954
D03.7 Melanoma in situ of lower limb, including hip	0.045	0.955
C71.2 Temporal lobe	0.045	0.955
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.045	0.955
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.044	0.955
C71.8 Overlapping lesion of brain	0.044	0.956
C71.7 Brain stem	0.044	0.956
C71.6 Cerebellum	0.044	0.956
C71.5 Cerebral ventricle	0.044	0.956
C71.9 Brain, unspecified	0.044	0.956
D47.1 Chronic myeloproliferative disease	0.044	0.956
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.044	0.956
D03.9 Melanoma in situ, unspecified	0.044	0.956
D03.8 Melanoma in situ of other sites	0.044	0.956
D03.2 Melanoma in situ of ear and external auricular canal	0.044	0.956
D03.1 Melanoma in situ of eyelid, including canthus	0.044	0.956
D03.0 Melanoma in situ of lip	0.044	0.956
D02 Carcinoma in situ of middle ear and respiratory system	0.044	0.956
D01 Carcinoma in situ of other and unspecified digestive organs	0.044	0.956
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.044	0.956
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.043	0.956
C95 Leukaemia of unspecified cell type	0.043	0.956
C94 Other leukaemias of specified cell type	0.043	0.956
C93 Monocytic leukaemia	0.043	0.956
C88 Malignant immunoproliferative diseases	0.043	0.956
C86 Other specified types of T/NK-cell lymphoma	0.043	0.956
C84 Peripheral and cutaneous T-cell lymphomas	0.043	0.956
C91.4 Hairy-cell leukaemia	0.043	0.957
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.043	0.957
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.043	0.957
C81 Hodgkin's disease	0.043	0.957
D03.4 Melanoma in situ of scalp and neck	0.042	0.957
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.042	0.958
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.042	0.958
D04 Carcinoma in situ of skin	0.042	0.958
D45 Polycythaemia vera	0.042	0.958
C91.9 Lymphoid leukaemia, unspecified	0.041	0.959
C91.8 Mature B-cell leukaemia Burkitt-type	0.041	0.959
C91.7 Other lymphoid leukaemia	0.041	0.959
C91.6 Prolymphocytic leukaemia of T-cell type	0.041	0.959
C91.5 Adult T-cell leukaemia	0.041	0.959
C91.3 Prolymphocytic leukaemia	0.041	0.959
C91.2 Subacute lymphocytic leukaemia	0.041	0.959
C91.0 Acute lymphoblastic leukaemia	0.041	0.959
D06 Carcinoma in situ of cervix uteri	0.041	0.959
D43.0 Brain, supratentorial	0.041	0.959
D09 Carcinoma in situ of other and unspecified sites	0.041	0.959
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.040	0.960
C46 Kaposi's sarcoma	0.040	0.960
D47.2 Monoclonal gammopathy	0.040	0.960
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.040	0.960
C49.1 Connective and soft tissue of upper limb, including shoulder	0.040	0.960
C65 Malignant neoplasm of renal pelvis	0.040	0.960
C90 Multiple myeloma and malignant plasma cell neoplasms	0.040	0.960
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.040	0.960
D47.4 Osteomyelofibrosis	0.040	0.960
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.039	0.960
C49.5 Connective and soft tissue of pelvis	0.039	0.961
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.039	0.961
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.039	0.961
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.039	0.961
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.039	0.961
C68 Malignant neoplasm of other and unspecified urinary organs	0.039	0.961
D07 Carcinoma in situ of other and unspecified genital organs	0.039	0.961
C49.0 Connective and soft tissue of head, face and neck	0.039	0.961
D40.1 Testis	0.039	0.961
D43.2 Brain, unspecified	0.038	0.962
C48.0 Retroperitoneum	0.038	0.962
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.037	0.963
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.037	0.963
D44.3 Pituitary gland	0.037	0.963
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.037	0.963
C82.6 Cutaneous follicle centre lymphoma	0.037	0.963
C82.5 Diffuse follicle centre lymphoma	0.037	0.963
C82.4 Follicular lymphoma grade IIIb	0.037	0.963
C82.3 Follicular lymphoma grade IIIa	0.037	0.963
C82.2 Large cell, follicular	0.037	0.963
C82.1 Mixed small cleaved and large cell, follicular	0.037	0.963
C82.0 Small cleaved cell, follicular	0.037	0.963
C83.3 Large cell (diffuse)	0.037	0.963
D46 Myelodysplastic syndromes	0.036	0.963
C66 Malignant neoplasm of ureter	0.036	0.964
C49.9 Connective and soft tissue, unspecified	0.035	0.965
C49.8 Overlapping lesion of connective and soft tissue	0.035	0.965
C49.6 Connective and soft tissue of trunk, unspecified	0.035	0.965
C49.4 Connective and soft tissue of abdomen	0.035	0.965
C49.3 Connective and soft tissue of thorax	0.035	0.965
D43.9 Central nervous system, unspecified	0.035	0.965
D43.7 Other parts of central nervous system	0.035	0.965
D43.4 Spinal cord	0.035	0.965
D43.3 Cranial nerves	0.035	0.965
D43.1 Brain, infratentorial	0.035	0.965
C09 Malignant neoplasm of tonsil	0.035	0.965
D39.1 Ovary	0.035	0.965
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.034	0.965
C83.1 Small cleaved cell (diffuse)	0.034	0.966
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.034	0.966
C83.7 Burkitt's tumour	0.034	0.966
C83.6 Undifferentiated (diffuse)	0.034	0.966
C83.5 Lymphoblastic (diffuse)	0.034	0.966
C83.4 Immunoblastic (diffuse)	0.034	0.966
C83.2 Mixed small and large cell (diffuse)	0.034	0.966
C48.1 Specified parts of peritoneum	0.034	0.966
C92 Myeloid leukaemia	0.034	0.966
D40.9 Male genital organ, unspecified	0.034	0.966
D40.7 Other male genital organs	0.034	0.966
D40.0 Prostate	0.034	0.966
C49.2 Connective and soft tissue of lower limb, including hip	0.033	0.967
C70.9 Meninges, unspecified	0.033	0.967
C70.1 Spinal meninges	0.033	0.967
C70.0 Cerebral meninges	0.033	0.967
C72.9 Central nervous system, unspecified	0.033	0.967
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.033	0.967
C72.5 Other and unspecified cranial nerves	0.033	0.967
C72.4 Acoustic nerve	0.033	0.967
C72.3 Optic nerve	0.033	0.967
C72.2 Olfactory nerve	0.033	0.967
C72.1 Cauda equina	0.033	0.967
C72.0 Spinal cord	0.033	0.967
C69.9 Eye, unspecified	0.033	0.967
C69.8 Overlapping lesion of eye and adnexa	0.033	0.967
C69.6 Orbit	0.033	0.967
C69.5 Lachrymal gland and duct	0.033	0.967
C69.4 Ciliary body	0.033	0.967
C69.2 Retina	0.033	0.967
C69.1 Cornea	0.033	0.967
C69.0 Conjunctiva	0.033	0.967
C51-C58 Malignant neoplasms of female genital organs	0.033	0.967
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.033	0.967
D44.9 Endocrine gland, unspecified	0.033	0.967
D44.8 Pluriglandular involvement	0.033	0.967
D44.7 Aortic body and other paraganglia	0.033	0.967
D44.6 Carotid body	0.033	0.967
D44.5 Pineal gland	0.033	0.967
D44.4 Craniopharyngeal duct	0.033	0.967
D44.2 Parathyroid gland	0.033	0.967
D44.1 Adrenal gland	0.033	0.967
D44.0 Thyroid gland	0.033	0.967
D04.3 Skin of other and unspecified parts of face	0.033	0.967
C69.3 Choroid	0.033	0.967
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.032	0.967
D39.9 Female genital organ, unspecified	0.032	0.968
D39.7 Other female genital organs	0.032	0.968
D39.2 Placenta	0.032	0.968
D39.0 Uterus	0.032	0.968
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.032	0.968
C41.1 Mandible	0.032	0.968
C10 Malignant neoplasm of oropharynx	0.032	0.968
D04.2 Skin of ear and external auricular canal	0.032	0.968
D00.2 Stomach	0.031	0.968
D00.1 Oesophagus	0.031	0.968
D00.0 Lip, oral cavity and pharynx	0.031	0.968
D01.9 Digestive organ, unspecified	0.031	0.968
D01.7 Other specified digestive organs	0.031	0.968
D01.5 Liver, gallbladder and bile ducts	0.031	0.968
D01.4 Other and unspecified parts of intestine	0.031	0.968
D01.3 Anus and anal canal	0.031	0.968
D01.2 Rectum	0.031	0.968
D01.1 Rectosigmoid junction	0.031	0.968
D01.0 Colon	0.031	0.968
D02.4 Respiratory system, unspecified	0.031	0.968
D02.3 Other parts of respiratory system	0.031	0.968
D02.2 Bronchus and lung	0.031	0.968
D02.1 Trachea	0.031	0.968
D02.0 Larynx	0.031	0.968
C84.9 Mature T/NK-cell lymphoma, unspecified	0.031	0.968
C84.8 Cutaneous T-cell lymphoma, unspecified	0.031	0.968
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.031	0.968
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.031	0.968
C84.5 Other and unspecified T-cell lymphomas	0.031	0.968
C84.4 Peripheral T-cell lymphoma	0.031	0.968
C84.3 Lymphoepithelioid lymphoma	0.031	0.968
C84.2 T-zone lymphoma	0.031	0.968
C84.1 Sezary's diease	0.031	0.968
C84.0 Mycosis fungoides	0.031	0.968
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.031	0.968
C86.5 Angioimmunoblastic T-cell lymphoma	0.031	0.968
C86.4 Blastic NK-cell lymphoma	0.031	0.968
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.031	0.968
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.031	0.968
C86.1 Hepatosplenic T-cell lymphoma	0.031	0.968
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.031	0.968
C88.9 Malignant immunoproliferative disease, unspecified	0.031	0.968
C88.7 Other malignant immunoproliferative diseases	0.031	0.968
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.031	0.968
C88.3 Immunoproliferative small intestinal disease	0.031	0.968
C88.2 Gamma heavy chain disease	0.031	0.968
C88.1 Alpha heavy chain disease	0.031	0.968
C88.0 Waldenstrom's macroglobulinaemia	0.031	0.968
C93.9 Monocytic leukaemia, unspecified	0.031	0.968
C93.7 Other monocytic leukaemia	0.031	0.968
C93.3 Juvenile myelomonocytic leukaemia	0.031	0.968
C93.2 Subacute monocytic leukaemia	0.031	0.968
C93.1 Chronic monocytic leukaemia	0.031	0.968
C93.0 Acute monocytic leukaemia	0.031	0.968
C94.7 Other specified leukaemias	0.031	0.968
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.031	0.968
C94.5 Acute myelofibrosis	0.031	0.968
C94.4 Acute panmyelosis	0.031	0.968
C94.3 Mast cell leukaemia	0.031	0.968
C94.2 Acute megakaryoblastic leukaemia	0.031	0.968
C94.1 Chronic erythraemia	0.031	0.968
C94.0 Acute erythraemia and erythroleukaemia	0.031	0.968
C95.9 Leukaemia, unspecified	0.031	0.968
C95.7 Other leukaemia of unspecified cell type	0.031	0.968
C95.2 Subacute leukaemia of unspecified cell type	0.031	0.968
C95.1 Chronic leukaemia of unspecified cell type	0.031	0.968
C95.0 Acute leukaemia of unspecified cell type	0.031	0.968
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.031	0.968
C96.8 Histiocytic sarcoma	0.031	0.968
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.031	0.968
C96.6 Unifocal Langerhans-cell histiocytosis	0.031	0.968
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.031	0.968
C96.4 Sarcoma of dendritic cells (accessory cells)	0.031	0.968
C96.3 True histiocytic lymphoma	0.031	0.968
C96.2 Malignant mast cell tumour	0.031	0.968
C96.1 Malignant histiocytosis	0.031	0.968
C96.0 Letterer-Siwe disease	0.031	0.968
C02 Malignant neoplasm of other and unspecified parts of tongue	0.031	0.969
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.031	0.969
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.031	0.969
C13 Malignant neoplasm of hypopharynx	0.031	0.969
C11 Malignant neoplasm of nasopharynx	0.031	0.969
C08 Malignant neoplasm of other and unspecified major salivary glands	0.031	0.969
C06 Malignant neoplasm of other and unspecified parts of mouth	0.031	0.969
C05 Malignant neoplasm of palate	0.031	0.969
C04 Malignant neoplasm of floor of mouth	0.031	0.969
C03 Malignant neoplasm of gum	0.031	0.969
C00 Malignant neoplasm of lip	0.031	0.969
C12 Malignant neoplasm of pyriform sinus	0.031	0.969
C81.1 Nodular sclerosis	0.031	0.969
C81.7 Other Hodgkin's disease	0.031	0.969
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.031	0.969
C81.3 Lymphocytic depletion	0.031	0.969
C81.2 Mixed cellularity	0.031	0.969
C81.0 Lymphocytic predominance	0.031	0.969
D04.7 Skin of lower limb, including hip	0.031	0.969
C45 Mesothelioma	0.030	0.969
C75 Malignant neoplasm of other endocrine glands and related structures	0.030	0.969
C74 Malignant neoplasm of adrenal gland	0.030	0.969
D42.9 Meninges, unspecified	0.030	0.970
D42.1 Spinal meninges	0.030	0.970
D42.0 Cerebral meninges	0.030	0.970
D04.9 Skin, unspecified	0.030	0.970
D04.8 Skin of other sites	0.030	0.970
D04.4 Skin of scalp and neck	0.030	0.970
D04.1 Skin of eyelid, including canthus	0.030	0.970
D04.0 Skin of lip	0.030	0.970
C50-C50 Malignant neoplasm of breast	0.030	0.970
D06.7 Other parts of cervix	0.030	0.970
D06.1 Exocervix	0.030	0.970
D06.0 Endocervix	0.030	0.970
C81.9 Hodgkin's disease, unspecified	0.030	0.970
C48.2 Peritoneum, unspecified	0.030	0.970
D05 Carcinoma in situ of breast	0.030	0.970
D09.9 Carcinoma in situ, unspecified	0.029	0.970
D09.7 Carcinoma in situ of other specified sites	0.029	0.970
D09.3 Thyroid and other endocrine glands	0.029	0.970
D09.2 Eye	0.029	0.970
D09.1 Other and unspecified urinary organs	0.029	0.970
C67 Malignant neoplasm of bladder	0.029	0.971
C09.9 Tonsil, unspecified	0.029	0.971
C46.9 Kaposi's sarcoma, unspecified	0.029	0.971
C46.8 Kaposi's sarcoma of multiple organs	0.029	0.971
C46.7 Kaposi's sarcoma of other sites	0.029	0.971
C46.3 Kaposi's sarcoma of lymph nodes	0.029	0.971
C46.2 Kaposi's sarcoma of palate	0.029	0.971
C46.1 Kaposi's sarcoma of soft tissue	0.029	0.971
C46.0 Kaposi's sarcoma of skin	0.029	0.971
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.029	0.971
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.029	0.971
C47.6 Peripheral nerves of trunk, unspecified	0.029	0.971
C47.5 Peripheral nerves of pelvis	0.029	0.971
C47.4 Peripheral nerves of abdomen	0.029	0.971
C47.3 Peripheral nerves of thorax	0.029	0.971
C47.2 Peripheral nerves of lower limb, including hip	0.029	0.971
C47.1 Peripheral nerves of upper limb, including shoulder	0.029	0.971
C47.0 Peripheral nerves of head, face and neck	0.029	0.971
C41.9 Bone and articular cartilage, unspecified	0.029	0.971
C41.8 Overlapping lesion of bone and articular cartilage	0.029	0.971
C41.4 Pelvic bones, sacrum and coccyx	0.029	0.971
C41.3 Ribs, sternum and clavicle	0.029	0.971
C41.2 Vertebral column	0.029	0.971
C41.0 Bones of skull and face	0.029	0.971
D07.5 Prostate	0.029	0.971
C90.3 Solitary plasmacytoma	0.029	0.971
C90.1 Plasma cell leukaemia	0.029	0.971
D48.0 Bone and articular cartilage	0.029	0.971
C83.0 Small cell (diffuse)	0.029	0.971
D38.6 Respiratory organ, unspecified	0.028	0.971
D38.5 Other respiratory organs	0.028	0.971
D38.4 Thymus	0.028	0.971
D38.3 Mediastinum	0.028	0.971
D38.2 Pleura	0.028	0.971
D38.0 Larynx	0.028	0.971
C68.9 Urinary organ, unspecified	0.028	0.972
C68.8 Overlapping lesion of urinary organs	0.028	0.972
C68.1 Paraurethral glands	0.028	0.972
C68.0 Urethra	0.028	0.972
D07.6 Other and unspecified male genital organs	0.028	0.972
D07.4 Penis	0.028	0.972
D07.3 Other and unspecified female genital organs	0.028	0.972
D07.2 Vagina	0.028	0.972
D07.0 Endometrium	0.028	0.972
C90.2 Plasmacytoma, extramedullary	0.028	0.972
D06.9 Cervix, unspecified	0.027	0.973
C40.9 Bone and articular cartilage of limb, unspecified	0.027	0.973
C40.8 Overlapping lesion of bone and articular cartilage of limbs	0.027	0.973
C40.3 Short bones of lower limb	0.027	0.973
C40.2 Long bones of lower limb	0.027	0.973
C40.1 Short bones of upper limb	0.027	0.973
C40.0 Scapula and long bones of upper limb	0.027	0.973
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)	0.027	0.973
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)	0.027	0.973
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)	0.027	0.973
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)	0.027	0.973
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)	0.027	0.973
C55 Malignant neoplasm of uterus, part unspecified	0.027	0.973
D09.0 Bladder	0.027	0.973
D04.5 Skin of trunk	0.027	0.973
D46.7 Other myelodysplastic syndromes	0.026	0.974
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.026	0.974
D46.5 Refractory anaemia with multi-lineage dysplasia	0.026	0.974
D46.4 Refractory anaemia, unspecified	0.026	0.974
D46.3 Refractory anaemia with excess of blasts with transformation	0.026	0.974
D46.2 Refractory anaemia with excess of blasts	0.026	0.974
D46.1 Refractory anaemia with sideroblasts	0.026	0.974
D46.0 Refractory anaemia without sideroblasts, so stated	0.026	0.974
D38.1 Trachea, bronchus and lung	0.026	0.974
C07 Malignant neoplasm of parotid gland	0.026	0.974
C90.0 Multiple myeloma	0.026	0.974
C97 Malignant neoplasms of independent (primary) multiple sites	0.025	0.974
C92.1 Chronic myeloid leukaemia	0.025	0.974
C09.8 Overlapping lesion of tonsil	0.025	0.975
C09.1 Tonsillar pillar (anterior) (posterior)	0.025	0.975
C09.0 Tonsillar fossa	0.025	0.975
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.025	0.975
D48.4 Peritoneum	0.025	0.975
D48.3 Retroperitoneum	0.025	0.975
D48.2 Peripheral nerves and autonomic nervous system	0.025	0.975
C02.1 Border of tongue	0.025	0.975
C57 Malignant neoplasm of other and unspecified female genital organs	0.025	0.975
C52 Malignant neoplasm of vagina	0.025	0.975
C92.9 Myeloid leukaemia, unspecified	0.024	0.975
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.024	0.975
C92.7 Other myeloid leukaemia	0.024	0.975
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.024	0.975
C92.5 Acute myelomonocytic leukaemia	0.024	0.975
C92.4 Acute promyelocytic leukaemia	0.024	0.975
C92.3 Myeloid sarcoma	0.024	0.975
C92.2 Subacute myeloid leukaemia	0.024	0.975
D48.1 Connective and other soft tissue	0.025	0.975
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.024	0.976
C38 Malignant neoplasm of heart, mediastinum and pleura	0.024	0.976
C31 Malignant neoplasm of accessory sinuses	0.024	0.976
C30 Malignant neoplasm of nasal cavity and middle ear	0.024	0.976
C37 Malignant neoplasm of thymus	0.024	0.976
C33 Malignant neoplasm of trachea	0.024	0.976
C58 Malignant neoplasm of placenta	0.024	0.976
D04.6 Skin of upper limb, including shoulder	0.024	0.976
C10.9 Oropharynx, unspecified	0.024	0.976
C01 Malignant neoplasm of base of tongue	0.024	0.976
C73 Malignant neoplasm of thyroid gland	0.024	0.976
C67.6 Ureteric orifice	0.024	0.976
D05.7 Other carcinoma in situ of breast	0.024	0.976
D41.0 Kidney	0.024	0.976
D41.9 Urinary organ, unspecified	0.023	0.977
D41.7 Other urinary organs	0.023	0.977
D41.3 Urethra	0.023	0.977
D41.2 Ureter	0.023	0.977
D41.1 Renal pelvis	0.023	0.977
C10.8 Overlapping lesion of oropharynx	0.023	0.977
C10.4 Branchial cleft	0.023	0.977
C10.3 Posterior wall of oropharynx	0.023	0.977
C10.2 Lateral wall of oropharynx	0.023	0.977
C10.1 Anterior surface of epiglottis	0.023	0.977
C10.0 Vallecula	0.023	0.977
C67.3 Anterior wall of bladder	0.023	0.977
D48.7 Other specified sites	0.023	0.977
C02.8 Overlapping lesion of tongue	0.023	0.977
C02.4 Lingual tonsil	0.023	0.977
C02.3 Anterior two-thirds of tongue, part unspecified	0.023	0.977
C02.2 Ventral surface of tongue	0.023	0.977
C02.0 Dorsal surface of tongue	0.023	0.977
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.023	0.977
C85.0 Lymphosarcoma	0.023	0.977
C85.7 Other specified types of non-Hodgkin's lymphoma	0.023	0.977
C00.9 Lip, unspecified	0.022	0.977
C00.8 Overlapping lesion of lip	0.022	0.977
C00.6 Commissure of lip	0.022	0.977
C00.5 Lip, unspecified, inner aspect	0.022	0.977
C00.4 Lower lip, inner aspect	0.022	0.977
C00.3 Upper lip, inner aspect	0.022	0.977
C00.2 External lip, unspecified	0.022	0.977
C00.1 External lower lip	0.022	0.977
C00.0 External upper lip	0.022	0.977
C03.9 Gum, unspecified	0.022	0.977
C03.1 Lower gum	0.022	0.977
C03.0 Upper gum	0.022	0.977
C04.9 Floor of mouth, unspecified	0.022	0.977
C04.8 Overlapping lesion of floor of mouth	0.022	0.977
C04.1 Lateral floor of mouth	0.022	0.977
C04.0 Anterior floor of mouth	0.022	0.977
C05.9 Palate, unspecified	0.022	0.977
C05.8 Overlapping lesion of palate	0.022	0.977
C05.2 Uvula	0.022	0.977
C05.1 Soft palate	0.022	0.977
C05.0 Hard palate	0.022	0.977
C06.9 Mouth, unspecified	0.022	0.977
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.022	0.977
C06.2 Retromolar area	0.022	0.977
C06.1 Vestibule of mouth	0.022	0.977
C06.0 Cheek mucosa	0.022	0.977
C08.9 Major salivary gland, unspecified	0.022	0.977
C08.8 Overlapping lesion of major salivary glands	0.022	0.977
C08.1 Sublingual gland	0.022	0.977
C08.0 Submandibular gland	0.022	0.977
C11.9 Nasopharynx, unspecified	0.022	0.977
C11.8 Overlapping lesion of nasopharynx	0.022	0.977
C11.3 Anterior wall of nasopharynx	0.022	0.977
C11.2 Lateral wall of nasopharynx	0.022	0.977
C11.1 Posterior wall of nasopharynx	0.022	0.977
C11.0 Superior wall of nasopharynx	0.022	0.977
C13.9 Hypopharynx, unspecified	0.022	0.977
C13.8 Overlapping lesion of hypopharynx	0.022	0.977
C13.2 Posterior wall of hypopharynx	0.022	0.977
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.022	0.977
C13.0 Postcricoid region	0.022	0.977
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.022	0.977
C14.2 Waldeyer's ring	0.022	0.977
C14.0 Pharynx, unspecified	0.022	0.977
C85.1 B-cell lymphoma, unspecified	0.023	0.977
C60-C63 Malignant neoplasms of male genital organs	0.022	0.977
C67.0 Trigone of bladder	0.022	0.978
C45.7 Mesothelioma of other sites	0.022	0.978
C45.2 Mesothelioma of pericardium	0.022	0.978
C45.1 Mesothelioma of peritoneum	0.022	0.978
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.022	0.978
C74.9 Adrenal gland, unspecified	0.022	0.978
C74.1 Medulla of adrenal gland	0.022	0.978
C74.0 Cortex of adrenal gland	0.022	0.978
C75.9 Endocrine gland, unspecified	0.022	0.978
C75.8 Pluriglandular involvement, unspecified	0.022	0.978
C75.5 Aortic body and other paraganglia	0.022	0.978
C75.4 Carotid body	0.022	0.978
C75.3 Pineal gland	0.022	0.978

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations